Skip to main content

Table 3 Demography, outcome, admission hematology, coagulopathy and blood transfusion in massively transfused patients (> 10 RBC the initial 0-24 h) in each study period (2001-3 and 2005-7).

From: Blood product ratio in acute traumatic coagulopathy - effect on mortality in a Scandinavian level 1 trauma centre

  

Study period

2001-3

Study period

2005-7

P-value1

n

 

21

45

 

Age

years

50 (35-69)

40 (28-52)

0.106

Gender

male

16 (76%)

32 (71%)

0.666

ISS

score

26 (17-34)

27 (19-36)

0.694

Mortality

deceased

7 (37%)

17 (39%)

0.893

Hemoglobin

mmol/l

5.7 (4.6-6.8)

6.7 (5.6-7.6)

0.066

Platelet count

< 150*109/l

8 (53%)

17 (44%)

0.520

APTT

> 35 s

9 (60%)

24 (62%)

0.917

INR

> 1.2

11 (73%)

21 (54%)

0.192

Time to first blood product

min

28 (22-65)

3 (0-23)

< 0.001

RBC 0-6 h

n

12 (12-24)

20 (14-30)

0.0394

RBC total

n

14 (12-23)

20 (14-30)

0.0933

FFP 0-6 h

n

5 (4-10)

14 (10-20)

< 0.001

FFP total

n

6 (4-12)

14 (10-21)

< 0.001

PLT 0-6 h

n

0 (0-1)

6 (4-8)

< 0.001

PLT total

n

0 (0-2)

6 (4-8)

< 0.001

FFP:RBC 0-6 h

ratio

0.33 (0.16-0.53)

0.71 (0.59-0.85)

< 0.001

FFP:RBC total

ratio

0.36 (0.24-0.59)

0.74 (0.61-0.85)

< 0.001

PLT:RBC 0-6 h

ratio

0 (0-0.05)

0.29 (0.20-0.37)

< 0.001

PLT:RBC total

ratio

0 (0-0.05)

0.29 (0.20-0.35)

< 0.001

PLT:FFP 0-6 h

ratio

0 (0-0.10)

0.40 (0.36-0.43)

< 0.001

PLT:FFP total

ratio

0 (0-0.13)

0.40 (0.35-0.46)

< 0.001

  1. 1Patients from period 1 and 2 were compared by Wilcoxon Rank Sum test. Data are presented as medians (IQR), with p-values in bold for variables with p < 0.05.
Back to article page